Colin Weller

Nov 5, 2024 | clinicalleader.com | Dan Schell |Ben Baumann |Colin Weller

Webinar: Unleash the Power of IQVIA Complete ConsentThe eConsent market is evolving, focusing on improving patient experiences, streamlining clinical trial processes, and global expansion. Staying informed on industry developments is crucial.

Aug 2, 2024 | clinicalleader.com | Colin Weller

By Colin Weller, General Manager, Platform and Digital Solutions The clinical research industry is currently shifting towards patient-centric approaches and utilizing digital biomarkers and endpoints to enhance the efficiency and precision of evidence generation. Medable recognizes the effectiveness of wearable technology and digital endpoints in trials for Duchenne Muscular Dystrophy, which has resulted in significant cost and time savings.

Aug 2, 2024 | clinicalleader.com | Colin Weller

By Colin Weller, VP, Product Management The pharmaceutical industry faces challenges in bringing new drugs to patients, primarily due to the lengthy clinical trial process. One of the key factors contributing to the acceleration of clinical trials is the adoption of digital health technologies. These technologies have brought about significant improvements in trial timelines.

Jan 26, 2024 | clinicalleader.com | Colin Weller

Article | January 26, 2024 By Colin Weller, General Manager, Platform and Digital Solutions In the clinical research industry, tools like Digital Biomarkers and Endpoints are transforming evidence generation. A recent NIH-published study highlights the regulatory qualification of a digital measure of ambulation, SV95C, setting a crucial precedent for wearable technology in Duchenne Muscular Dystrophy trials.

Jan 17, 2024 | clinicalleader.com | Colin Weller

Article | January 17, 2024 By Michelle Longmire MD CEO and Colin Weller, GM Digital Endpoints and Measures By 2024, significant advancements in digital and artificial intelligence are expected to revolutionize the landscape of clinical development. The use of digital biomarkers in clinical trials is anticipated to increase, enabling real-time, accurate health data collection through wearable devices, mobile apps, and remote monitoring tools.